Results 171 to 180 of about 87,449 (274)
The early injected genomic region determines sensitivity to Type I restriction-modification defence against Autographiviridae phages. [PDF]
Martinez-Cazorla A +5 more
europepmc +1 more source
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz +3 more
wiley +1 more source
A 3D disease model is developed using customized hyaluronic‐acid‐based hydrogels supplemented with extracellular matrix (ECM) proteins resembling brain ECM properties. Neurons, astrocytes, and tumor cells are used to mimic the native brain surrounding.
Esra Türker +16 more
wiley +1 more source
Anti-plasmid defense in hypervirulent <i>Klebsiella pneumoniae</i> involves Type I-like and Type IV restriction modification systems. [PDF]
Oo G +7 more
europepmc +1 more source
We introduce a nucleic acid nanoparticle (NANP) platform designed to be rrecognized by the human innate immune system in a regulated manner. By changing chemical composition while maintaining constant architectural parameters, we identify key determinants of immunorecognition enabling the rational design of NANPs with tunable immune activation profiles
Martin Panigaj +21 more
wiley +1 more source
Advances in Diversity, Evolutionary Dynamics and Biotechnological Potential of Restriction-Modification Systems. [PDF]
Chen C, Zhang Y, Wu H, Qiao J, Caiyin Q.
europepmc +1 more source
This research presents a novel implantable bio‐battery, GF‐OsG, tailored for diabetic bone repair. GF‐OsG generates microcurrents in high‐glucose conditions to enhance vascularization, shift macrophages to the M2 phenotype, and regulate immune responses.
Nanning Lv +10 more
wiley +1 more source
Methodological landscape in the field of integration site identification of retroviruses and retroviral vectors. [PDF]
Kochergin-Nikitsky K +2 more
europepmc +1 more source
A multivalent antiviral platform based on honeycomb‐shaped DNA nanostructures (HC–Urumin) is developed to enhance the potency and breadth of the host defense peptide Urumin. Through spatially patterned trimeric presentation, HC–Urumin disrupts influenza A virus entry, improves cell viability, and reduces disease severity in vivo‐offering a modular and ...
Saurabh Umrao +11 more
wiley +1 more source
A new family of small ArdA proteins reveals antirestriction activity. [PDF]
Utkina AA +6 more
europepmc +1 more source

